Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market. - Abstract - Europe PMC
Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market. - Abstract - Europe PMC
Uvršteni novi lijekovi na liste lijekova HZZO-a | HZZO
Novi lijekovi na listama lijekova | HZZO
Lijekovi | HZZO
Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market. - Abstract - Europe PMC
Access to orphan drugs – comparison across Balkan countries - ScienceDirect
Novi lijekovi na listama lijekova | HZZO
Personalized Medicine and Personalized Pricing: Degrees of Price Discrimination | SpringerLink
NOVI MODEL UPUĆIVANJA 2013
Evaluation of accordance of antibiotics package size with recommended treatment duration of guidelines for sore throat and urinary tract infections | Antimicrobial Resistance & Infection Control | Full Text
Outpatient benzodiazepine utilization in Croatia: drug use or misuse | SpringerLink
Popis lijekova za kolovoz 2021. | Antidoping HZJZ
Pharmaceutical pricing in Croatia: a comparison of ordinances in 2013 versus 2009 and their potential savings to provide future guidance - GaBI Journal
Personalized Medicine and Personalized Pricing: Degrees of Price Discrimination | springerprofessional.de
Sponzoriranje i promocija lijekova : usporedba javnih podataka u SAD-u 2013. i 2014. godine
HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE P R A
Frontiers | Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE P R A
Novi peroralni antikoagulansi u prevenciji moždanog udara kod bolesnika s atrijskom fibrilacijom
Full article: Transposition and implementation of EU rare disease policy in Eastern Europe
Bilijon - Novosti
HZZO - Pretraživanje liste lijekova
